http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2009148264-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
| filingDate | 2009-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2009148264-A |
| titleOfInvention | PHARMACEUTICAL COMPOSITION FOR LOCAL USE WITH ANTIBACTERIAL, ANTI-INFLAMMATORY AND IMMUNOMODULATING ACTION, AND ITS APPLICATIONS |
| abstract | 1. The use of a combination containing therapeutically effective amounts of a pharmaceutically acceptable compound of zinc, ascorbic acid or its pharmaceutically acceptable salt and succinic acid or its pharmaceutically acceptable salt, to increase the effectiveness of the antibacterial drug for local use. ! 2. The use according to claim 1, where the antibacterial drug is selected from the group consisting of chlorhexidine, amylmethacresol, gramicidin, cetylpyridinium chloride, dequalinium chloride, benzalkonium chloride and ambazon. ! 3. The use according to claim 2, where the antibacterial drug is chlorhexidine. ! 4. A topical pharmaceutical composition having antibacterial, anti-inflammatory and immunomodulatory effects, comprising a therapeutically effective amount of an antibacterial drug in combination with therapeutically effective amounts of a pharmaceutically acceptable compound of zinc, ascorbic acid or its pharmaceutically acceptable salt and succinic acid or its pharmaceutically acceptable salt, and pharmaceutically acceptable additives. ! 5. The pharmaceutical composition according to claim 4, where the antibacterial drug is selected from the group consisting of chlorhexidine, amylmethacresol, gramicidin, cetylpyridinium chloride, dequalinium chloride, benzalkonium chloride and ambazone. ! 6. The pharmaceutical composition according to claim 4, intended for the prevention and treatment of acute and chronic infectious and inflammatory diseases of the oral cavity and nasopharynx. ! 7. The pharmaceutical composition according to claim 6, where the disease is selected from g |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111658626-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2619848-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111658626-B |
| priorityDate | 2009-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 45.